Who owns BioMarin Pharmaceutical?

Key details on BioMarin Pharmaceutical (Ticker: BMRN)

Who owns BioMarin Pharmaceutical?

Is BMRN a good stock to own? Find out who bought BioMarin Pharmaceutical, who sold BioMarin Pharmaceutical (BMRN) stock, and who holds a large position in BioMarin Pharmaceutical.

Fund Name Number of Shares Share Valuation As Of
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 38.66M $38.27M March 31, 2015
Vanguard 22.24M $2.34B Sept. 30, 2015
Capital Research Global Investors^ 18.94M $1.99B Sept. 30, 2015
FMR 16.59M $1.75B Sept. 30, 2015
Sands Capital Management 11.40M $1.20B Sept. 30, 2015
T. Rowe Price Associates 7.54M $793.66M Sept. 30, 2015
PRIMECAP Management Company 7.37M $775.69M Sept. 30, 2015
Columbia Wanger Asset Management 5.67M $279.40M Dec. 31, 2012
JPMORGAN CHASE & CO 5.16M $547.54M Sept. 30, 2015
Jennison Associates 5.10M $537.35M Sept. 30, 2015
WINSLOW CAPITAL MANAGEMENT INC /MN 4.82M $328.84M March 31, 2014
Altrinsic Global Advisors 4.11M $141.20M Dec. 31, 2011
Baker Bros. Advisors 4.08M $429.32M Sept. 30, 2015
Inves 3.96M $156.73M June 30, 2012
STATE STREET CORPORATION 3.96M $285.63M Sept. 30, 2014
Wells Fargo & Company 3.86M $271.68M Dec. 31, 2013
BlackRock Fund Advisors 3.84M $404.00M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 3.81M $401.69M Sept. 30, 2015
Capital World Investors^ 3.68M $205.21M June 30, 2013

Who sold BioMarin Pharmaceutical?

Fund Name Date Sold Number of Shares Sold Share Valuation
Cramer Rosenthal McGlynn Sept. 30, 2011 3.92M $125.08M
Sectoral Asset Management June 30, 2011 4.79M $130.30M
Munder Capital Management Dec. 31, 2010 3.95M $105.90M